Back to today’s briefing

Story perspectives

HCA Healthcare Surpasses EPS Estimates, Targeting $382

1/30/2025

46 10

Summary

Story summary

HCA Healthcare holds a "Moderate Buy" consensus rating from 18 analysts, targeting $382.19 for the year.
Truist and Royal Bank of Canada set recent price targets at $390.00 and $384.00, respectively.
HCA's EPS of $6.22 surpassed estimates, and it announced a quarterly dividend of $0.72.
Fresenius Medical Care achieved a 52-week high of $25.06, receiving a "buy" rating from Berenberg Bank.

1 of 1

Story summary

HCA Healthcare holds a "Moderate Buy" consensus rating from 18 analysts, targeting $382.19 for the year.
Truist and Royal Bank of Canada set recent price targets at $390.00 and $384.00, respectively.
HCA's EPS of $6.22 surpassed estimates, and it announced a quarterly dividend of $0.72.
Fresenius Medical Care achieved a 52-week high of $25.06, receiving a "buy" rating from Berenberg Bank.